O
OrbiMed’s AbCellera Biologics ABCL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.5M | Sell |
3,344,568
-836,200
| -20% | -$2.87M | 0.29% | 55 |
|
2025
Q1 | $9.32M | Hold |
4,180,768
| – | – | 0.22% | 63 |
|
2024
Q4 | $12.2M | Hold |
4,180,768
| – | – | 0.25% | 67 |
|
2024
Q3 | $10.9M | Hold |
4,180,768
| – | – | 0.2% | 78 |
|
2024
Q2 | $12.4M | Hold |
4,180,768
| – | – | 0.24% | 68 |
|
2024
Q1 | $18.9M | Hold |
4,180,768
| – | – | 0.35% | 67 |
|
2023
Q4 | $23.9M | Hold |
4,180,768
| – | – | 0.48% | 60 |
|
2023
Q3 | $19.2M | Hold |
4,180,768
| – | – | 0.41% | 64 |
|
2023
Q2 | $27M | Hold |
4,180,768
| – | – | 0.49% | 61 |
|
2023
Q1 | $31.5M | Hold |
4,180,768
| – | – | 0.62% | 53 |
|
2022
Q4 | $42.4M | Hold |
4,180,768
| – | – | 0.81% | 47 |
|
2022
Q3 | $41.3K | Hold |
4,180,768
| – | – | 0.77% | 48 |
|
2022
Q2 | $44.5K | Hold |
4,180,768
| – | – | 0.81% | 40 |
|
2022
Q1 | $40.8M | Hold |
4,180,768
| – | – | 0.66% | 44 |
|
2021
Q4 | $59.8M | Hold |
4,180,768
| – | – | 0.77% | 43 |
|
2021
Q3 | $83.8M | Sell |
4,180,768
-2,042,251
| -33% | -$40.9M | 0.92% | 33 |
|
2021
Q2 | $137M | Sell |
6,223,019
-1,977,749
| -24% | -$43.5M | 1.38% | 20 |
|
2021
Q1 | $278M | Sell |
8,200,768
-200,000
| -2% | -$6.79M | 2.6% | 9 |
|
2020
Q4 | $338M | Buy |
+8,400,768
| New | +$338M | 2.96% | 5 |
|